Tenaya Therapeutics (TNYA) Shares Outstanding (2020 - 2026)

Tenaya Therapeutics has reported Shares Outstanding for 7 years, with the latest figure at $217.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 33.41% year-over-year to $217.0 million; the trailing twelve-month figure through Mar 2026 stood at $217.0 million (up 33.41% YoY), and the FY2025 full-year result was $216.8 million, up 150.47% from the prior year.
• Shares Outstanding for Q1 2026 stood at $217.0 million, roughly flat from $216.8 million in the prior quarter.
• The five-year high for Shares Outstanding was $217.0 million in Q1 2026, with the low at $41.3 million in Q1 2022.
• Average Shares Outstanding over 5 years is $100.5 million, with a median of $78.5 million recorded in 2024.
• Peak annual rise in Shares Outstanding reached 3283.15% in 2022, while the deepest fall reached 0.23% in 2022.
• Tracing TNYA's Shares Outstanding over 5 years: stood at $66.9 million in 2022, then increased by 2.2% to $68.3 million in 2023, then grew by 26.65% to $86.5 million in 2024, then surged by 150.47% to $216.8 million in 2025, then advanced by 0.11% to $217.0 million in 2026.
• The last three Shares Outstanding figures came in at $217.0 million (Q1 2026), $216.8 million (Q4 2025), and $163.7 million (Q3 2025), per Business Quant data.

Peer Comparison